InsidersTradesSigma
Track the Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China stock price and the full directors' dealings record of the company, a publicly traded company based in Italy. Shares are listed on the IT market, under the supervision of Consob. Operating in the Health Care sector, Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China has published 1 insider filings. Market capitalisation: €796.7m. The latest transaction was disclosed on 18 November 2024 (Other). Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,619 of 29,062 companies
61.7
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 November 2024
Acerca de Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China
Pharmanutra S.p.a. es una empresa centrada en el sector de la salud y farmacéutico. Recientemente informó sus primeros resultados de ventas significativos en China.